Currently, there are 2.61B common shares owned by the public and among those 2.40B shares have been available to trade.
Insiders at the company have transacted a total of 59 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, accounting for 193,748 shares. Insider sales of the common stock occurred on 34 occasions, with total insider shares sold totaling 138,919 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of 0.05% and 6.66% over the past three months. JNJ shares are trading 3.66% year to date (YTD), with the 12-month market performance down to -4.16% lower. It has a 12-month low price of $144.95 and touched a high of $175.97 over the same period. JNJ has an average intraday trading volume of 6.77 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.04%, 4.54%, and 1.54% respectively.
Institutional ownership of Johnson & Johnson (NYSE: JNJ) shares accounts for 70.76% of the company’s 2.61B shares outstanding.
It has a market capitalization of $391.11B and a beta (3y monthly) value of 0.54. The stock’s trailing 12-month PE ratio is 31.01, while the earnings-per-share (ttm) stands at $5.24. The company has a PEG of 5.96 and a Quick Ratio of 0.96 with the debt-to-equity ratio at 0.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.13% over the week and 1.17% over the month.
Analysts forecast that Johnson & Johnson (JNJ) will achieve an EPS of $JNK for the current quarter, $107.44 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $SPDR Bloomberg High Yield Bond while analysts give the company a high EPS estimate of $Brookfield Finance Inc. 4.50% P. Comparatively, EPS for the current quarter was $Entergy New Orleans, LLC First a year ago. Earnings per share for the fiscal year are expected to decrease by -2.28%, and 7.66% over the next financial year. EPS should shrink at an annualized rate of 5.20% over the next five years, compared to 70.31% over the past 5-year period.
Looking at the support for the JNJ, a number of firms have released research notes about the stock. Wells Fargo stated their Equal Weight rating for the stock in a research note on December 13, 2023, with the firm’s price target at $170-$163.
